Grantham, Mayo, Van Otterloo & Co. LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1352662
Boston, MA
Position in HRMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$396,541
+$83,334 QoQ
Shares Held
10,891
-2.6% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#202
of 328 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $101,442,658 across 6 Biotechnology names. HRMY ranks #4 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
74,200 | $46,266,668 | |
| 2 | INCY |
Incyte Corp
|
318,584 | $36,114,682 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
137,395 | $18,236,438 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
10,891 | $396,541 | |
| 5 | ALT |
Altimmune, Inc.
|
83,837 | $254,864 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
28,344 | $173,465 |
All Filings in HRMY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $396,541 | 10,891 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $313,207 | 11,182 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $200,982 | 5,371 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||